Skip to main content
. 2022 Aug 4;13:887833. doi: 10.3389/fphar.2022.887833

FIGURE 7.

FIGURE 7

PD increases the antioxidant capacity of cochlea after cisplatin administration. Representative immunofluorescence labelling in the cochlea for Nrf2 (green, (A) and HO-1 (green, (B), double stained with DAPI in blue. The three dotted areas are SGNs, OHCs and SV. (A) and (B) In the control group, Nrf2 and HO-1 were slightly expressed in SGNs, OHCs and SV. After cisplatin administration, Nrf2 translocation into the nucleus was increased, along with the increased expression of Nrf2 and HO-1, and the green fluorescence intensity was slightly increased. The expression of Nrf2 and HO-1 was increased by PD and DEX before cisplatin administration, and the green fluorescence intensity was higher than that of CDDP group. Scale bar, 100 μm.